A 3-year-old child presents with severe hypoglycemia (blood glucose 28 mg/dL) and hepatomegaly during a 6-hour fast. The child is lethargic and has seizure-like activity. Serum lactate is elevated at 8 mmol/L (normal <2). The parents report recurrent episodes after fasting or illness. Which investigation would best confirm a defect in gluconeogenesis?

Explanation

## Diagnostic Approach to Gluconeogenesis Defects ### Clinical Context This child presents with **fasting hypoglycemia with lactic acidosis** — a hallmark pattern of gluconeogenesis impairment. The elevated lactate and normal/low insulin (implying the liver cannot respond to hypoglycemia) point to a hepatic enzyme defect rather than insulin excess. ### Why Glucagon Stimulation Test? **Key Point:** The glucagon stimulation test (or prolonged fast with glucagon challenge) is the **gold standard screening investigation** for gluconeogenesis defects because: 1. **Glucagon bypasses insulin-mediated pathways** — it directly activates hepatic glycogenolysis and gluconeogenesis via cAMP 2. **Failure to raise glucose despite glucagon** = hepatic glucose output defect (gluconeogenesis or glycogenolysis impairment) 3. **Lactate rises further** = substrate (pyruvate/lactate) accumulates because it cannot be converted to glucose 4. **Glucose-to-lactate ratio becomes diagnostic** — in gluconeogenesis defects, this ratio is typically <3 (normal >5) ### Interpretation Table | Finding | Normal Response | Gluconeogenesis Defect | |---------|-----------------|------------------------| | Glucose after glucagon | Rises >30 mg/dL | Minimal rise (<10 mg/dL) | | Lactate after glucagon | Unchanged or ↓ | **Rises further** | | Glucose:Lactate ratio | >5 | **<3** | | Insulin level | Suppressed (<2 mIU/L) | Suppressed | **High-Yield:** The **lactate paradox** — lactate rises when glucose should rise — is pathognomonic for gluconeogenesis defects (especially PEPCK, FBPase-1, or G6Pase deficiency). ### Why Not the Other Options? **Liver biopsy with enzyme assay** (Option B): - Invasive and not first-line screening - Requires specialized histochemistry; not available in all centers - Reserved for **confirmation after biochemical testing** **Urine organic acids & plasma amino acids** (Option C): - Useful for identifying **organic acidemias** (e.g., methylmalonic aciduria, propionic acidemia) - These cause lactic acidosis via different mechanisms (impaired pyruvate oxidation) - Not specific for gluconeogenesis defects **Fasting insulin & C-peptide** (Option D): - Rules out **hyperinsulinemic hypoglycemia** (opposite problem) - In gluconeogenesis defects, insulin is **appropriately suppressed** — the defect is not insulin-mediated - Does not confirm the specific hepatic enzyme defect ### Clinical Pearl **Gluconeogenesis defects (PEPCK, FBPase-1, G6Pase deficiency) present with fasting hypoglycemia + lactic acidosis + hepatomegaly.** The glucagon stimulation test distinguishes these from glycogen storage diseases (which respond to glucagon) and hyperinsulinemic hypoglycemia (which have elevated insulin).